nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Nucleoside Analog—Azathioprine—Crohn's disease	0.811	1	CiPCiCtD
Ganciclovir—SLC22A8—Mercaptopurine—Crohn's disease	0.0829	1	CbGbCtD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00266	0.0912	CbGpPWpGaD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00266	0.0912	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00224	0.0767	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00224	0.0767	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.00214	0.0733	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.00214	0.0733	CbGpPWpGaD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00187	0.064	CbGpPWpGaD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00187	0.064	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00145	0.0497	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00145	0.0497	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000533	0.0183	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000533	0.0183	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000448	0.0154	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000448	0.0154	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000374	0.0128	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000374	0.0128	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000332	0.0114	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000291	0.00996	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000291	0.00996	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000279	0.00956	CbGpPWpGaD
Ganciclovir—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00027	0.00353	CcSEcCtD
Ganciclovir—Migraine—Mesalazine—Crohn's disease	0.000268	0.0035	CcSEcCtD
Ganciclovir—Affect lability—Mesalazine—Crohn's disease	0.000268	0.0035	CcSEcCtD
Ganciclovir—Glaucoma—Prednisone—Crohn's disease	0.000263	0.00345	CcSEcCtD
Ganciclovir—Face oedema—Mesalazine—Crohn's disease	0.000263	0.00344	CcSEcCtD
Ganciclovir—Mood swings—Mesalazine—Crohn's disease	0.000258	0.00337	CcSEcCtD
Ganciclovir—Arthralgia—Mercaptopurine—Crohn's disease	0.000257	0.00336	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000255	0.00334	CcSEcCtD
Ganciclovir—Blood creatinine increased—Mesalazine—Crohn's disease	0.000255	0.00333	CcSEcCtD
Ganciclovir—Pancreatitis—Azathioprine—Crohn's disease	0.000253	0.00331	CcSEcCtD
Ganciclovir—Liver function test abnormal—Mesalazine—Crohn's disease	0.000251	0.00329	CcSEcCtD
Ganciclovir—Abscess—Prednisone—Crohn's disease	0.000251	0.00328	CcSEcCtD
Ganciclovir—Dry skin—Mesalazine—Crohn's disease	0.000249	0.00326	CcSEcCtD
Ganciclovir—Oedema—Mercaptopurine—Crohn's disease	0.000246	0.00322	CcSEcCtD
Ganciclovir—Pancytopenia—Azathioprine—Crohn's disease	0.000245	0.00321	CcSEcCtD
Ganciclovir—Cramp muscle—Mesalazine—Crohn's disease	0.000245	0.00321	CcSEcCtD
Ganciclovir—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000245	0.00321	CcSEcCtD
Ganciclovir—Nasopharyngitis—Mesalazine—Crohn's disease	0.000243	0.00318	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000242	0.0083	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000242	0.0083	CbGpPWpGaD
Ganciclovir—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000241	0.00316	CcSEcCtD
Ganciclovir—Gastritis—Mesalazine—Crohn's disease	0.000241	0.00315	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00024	0.00314	CcSEcCtD
Ganciclovir—Skin disorder—Mercaptopurine—Crohn's disease	0.000239	0.00313	CcSEcCtD
Ganciclovir—Abdominal distension—Mesalazine—Crohn's disease	0.000237	0.0031	CcSEcCtD
Ganciclovir—Dysphagia—Mesalazine—Crohn's disease	0.000235	0.00308	CcSEcCtD
Ganciclovir—Anorexia—Mercaptopurine—Crohn's disease	0.000235	0.00307	CcSEcCtD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000233	0.00798	CbGpPWpGaD
Ganciclovir—Eosinophilia—Mesalazine—Crohn's disease	0.000233	0.00305	CcSEcCtD
Ganciclovir—Pneumonia—Azathioprine—Crohn's disease	0.000231	0.00303	CcSEcCtD
Ganciclovir—Bronchospasm—Mesalazine—Crohn's disease	0.000231	0.00303	CcSEcCtD
Ganciclovir—Pancreatitis—Mesalazine—Crohn's disease	0.00023	0.00302	CcSEcCtD
Ganciclovir—Infestation—Azathioprine—Crohn's disease	0.00023	0.00301	CcSEcCtD
Ganciclovir—Infestation NOS—Azathioprine—Crohn's disease	0.00023	0.00301	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000228	0.00299	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000224	0.00294	CcSEcCtD
Ganciclovir—Pancytopenia—Mesalazine—Crohn's disease	0.000223	0.00292	CcSEcCtD
Ganciclovir—Neutropenia—Mesalazine—Crohn's disease	0.00022	0.00288	CcSEcCtD
Ganciclovir—Dysuria—Mesalazine—Crohn's disease	0.00022	0.00288	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000218	0.00286	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000218	0.00285	CcSEcCtD
Ganciclovir—Pollakiuria—Mesalazine—Crohn's disease	0.000217	0.00284	CcSEcCtD
Ganciclovir—Agranulocytosis—Azathioprine—Crohn's disease	0.000215	0.00281	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000215	0.00281	CcSEcCtD
Ganciclovir—Decreased appetite—Mercaptopurine—Crohn's disease	0.000214	0.0028	CcSEcCtD
Ganciclovir—Weight decreased—Mesalazine—Crohn's disease	0.000213	0.00278	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000213	0.00278	CcSEcCtD
Ganciclovir—Pneumonia—Mesalazine—Crohn's disease	0.000211	0.00276	CcSEcCtD
Ganciclovir—Infestation—Mesalazine—Crohn's disease	0.00021	0.00274	CcSEcCtD
Ganciclovir—Infestation NOS—Mesalazine—Crohn's disease	0.00021	0.00274	CcSEcCtD
Ganciclovir—Cataract—Prednisone—Crohn's disease	0.000208	0.00273	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000208	0.00272	CcSEcCtD
Ganciclovir—Haemoglobin—Azathioprine—Crohn's disease	0.000208	0.00272	CcSEcCtD
Ganciclovir—Haemorrhage—Azathioprine—Crohn's disease	0.000207	0.0027	CcSEcCtD
Ganciclovir—Renal failure—Mesalazine—Crohn's disease	0.000206	0.0027	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000205	0.00269	CcSEcCtD
Ganciclovir—Stomatitis—Mesalazine—Crohn's disease	0.000204	0.00267	CcSEcCtD
Ganciclovir—Jaundice—Mesalazine—Crohn's disease	0.000204	0.00267	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000204	0.00698	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000204	0.00698	CbGpPWpGaD
Ganciclovir—Urinary tract infection—Mesalazine—Crohn's disease	0.000204	0.00267	CcSEcCtD
Ganciclovir—Conjunctivitis—Mesalazine—Crohn's disease	0.000204	0.00267	CcSEcCtD
Ganciclovir—Vasculitis—Prednisone—Crohn's disease	0.000203	0.00266	CcSEcCtD
Ganciclovir—Sweating—Mesalazine—Crohn's disease	0.000201	0.00263	CcSEcCtD
Ganciclovir—Haematuria—Mesalazine—Crohn's disease	0.0002	0.00262	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000198	0.00259	CcSEcCtD
Ganciclovir—Agranulocytosis—Mesalazine—Crohn's disease	0.000196	0.00256	CcSEcCtD
Ganciclovir—Erythema multiforme—Azathioprine—Crohn's disease	0.000195	0.00256	CcSEcCtD
Ganciclovir—Body temperature increased—Mercaptopurine—Crohn's disease	0.000195	0.00255	CcSEcCtD
Ganciclovir—Haemoglobin—Mesalazine—Crohn's disease	0.000189	0.00247	CcSEcCtD
Ganciclovir—Rhinitis—Mesalazine—Crohn's disease	0.000189	0.00247	CcSEcCtD
Ganciclovir—Hepatitis—Mesalazine—Crohn's disease	0.000188	0.00246	CcSEcCtD
Ganciclovir—Haemorrhage—Mesalazine—Crohn's disease	0.000188	0.00246	CcSEcCtD
Ganciclovir—Pharyngitis—Mesalazine—Crohn's disease	0.000187	0.00244	CcSEcCtD
Ganciclovir—Mediastinal disorder—Azathioprine—Crohn's disease	0.000186	0.00244	CcSEcCtD
Ganciclovir—Neuropathy—Prednisone—Crohn's disease	0.000186	0.00244	CcSEcCtD
Ganciclovir—Urinary tract disorder—Mesalazine—Crohn's disease	0.000186	0.00243	CcSEcCtD
Ganciclovir—Oedema peripheral—Mesalazine—Crohn's disease	0.000185	0.00243	CcSEcCtD
Ganciclovir—Chills—Azathioprine—Crohn's disease	0.000185	0.00243	CcSEcCtD
Ganciclovir—Connective tissue disorder—Mesalazine—Crohn's disease	0.000185	0.00242	CcSEcCtD
Ganciclovir—Arrhythmia—Azathioprine—Crohn's disease	0.000185	0.00241	CcSEcCtD
Ganciclovir—Urethral disorder—Mesalazine—Crohn's disease	0.000184	0.00241	CcSEcCtD
Ganciclovir—Alopecia—Azathioprine—Crohn's disease	0.000183	0.00239	CcSEcCtD
Ganciclovir—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000181	0.00237	CcSEcCtD
Ganciclovir—Oesophagitis—Prednisone—Crohn's disease	0.000181	0.00237	CcSEcCtD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000181	0.0062	CbGpPWpGaD
Ganciclovir—Erythema multiforme—Mesalazine—Crohn's disease	0.000178	0.00233	CcSEcCtD
Ganciclovir—Tinnitus—Mesalazine—Crohn's disease	0.000175	0.0023	CcSEcCtD
Ganciclovir—Hyperkinesia—Prednisone—Crohn's disease	0.000173	0.00226	CcSEcCtD
Ganciclovir—Sepsis—Prednisone—Crohn's disease	0.000172	0.00225	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000171	0.00585	CbGpPWpGaD
Ganciclovir—Angiopathy—Mesalazine—Crohn's disease	0.000171	0.00223	CcSEcCtD
Ganciclovir—Euphoric mood—Prednisone—Crohn's disease	0.00017	0.00223	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00017	0.00582	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00017	0.00582	CbGpPWpGaD
Ganciclovir—Mediastinal disorder—Mesalazine—Crohn's disease	0.00017	0.00222	CcSEcCtD
Ganciclovir—Chills—Mesalazine—Crohn's disease	0.000169	0.00221	CcSEcCtD
Ganciclovir—Diarrhoea—Mercaptopurine—Crohn's disease	0.000169	0.00221	CcSEcCtD
Ganciclovir—Ill-defined disorder—Azathioprine—Crohn's disease	0.000167	0.00218	CcSEcCtD
Ganciclovir—Alopecia—Mesalazine—Crohn's disease	0.000166	0.00218	CcSEcCtD
Ganciclovir—Thrombophlebitis—Prednisone—Crohn's disease	0.000166	0.00218	CcSEcCtD
Ganciclovir—Anaemia—Azathioprine—Crohn's disease	0.000166	0.00217	CcSEcCtD
Ganciclovir—Mental disorder—Mesalazine—Crohn's disease	0.000165	0.00216	CcSEcCtD
Ganciclovir—Malaise—Azathioprine—Crohn's disease	0.000162	0.00212	CcSEcCtD
Ganciclovir—Flatulence—Mesalazine—Crohn's disease	0.000161	0.00211	CcSEcCtD
Ganciclovir—Leukopenia—Azathioprine—Crohn's disease	0.000161	0.00211	CcSEcCtD
Ganciclovir—Tension—Mesalazine—Crohn's disease	0.000161	0.0021	CcSEcCtD
Ganciclovir—Dysgeusia—Mesalazine—Crohn's disease	0.00016	0.0021	CcSEcCtD
Ganciclovir—Nervousness—Mesalazine—Crohn's disease	0.000159	0.00208	CcSEcCtD
Ganciclovir—Back pain—Mesalazine—Crohn's disease	0.000158	0.00207	CcSEcCtD
Ganciclovir—Muscle spasms—Mesalazine—Crohn's disease	0.000157	0.00206	CcSEcCtD
Ganciclovir—Vomiting—Mercaptopurine—Crohn's disease	0.000157	0.00205	CcSEcCtD
Ganciclovir—Rash—Mercaptopurine—Crohn's disease	0.000155	0.00203	CcSEcCtD
Ganciclovir—Dermatitis—Mercaptopurine—Crohn's disease	0.000155	0.00203	CcSEcCtD
Ganciclovir—Vision blurred—Mesalazine—Crohn's disease	0.000154	0.00202	CcSEcCtD
Ganciclovir—Tremor—Mesalazine—Crohn's disease	0.000153	0.00201	CcSEcCtD
Ganciclovir—Amnesia—Prednisone—Crohn's disease	0.000153	0.002	CcSEcCtD
Ganciclovir—Arthralgia—Azathioprine—Crohn's disease	0.000153	0.002	CcSEcCtD
Ganciclovir—Myalgia—Azathioprine—Crohn's disease	0.000153	0.002	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000152	0.00199	CcSEcCtD
Ganciclovir—Ill-defined disorder—Mesalazine—Crohn's disease	0.000152	0.00199	CcSEcCtD
Ganciclovir—Anaemia—Mesalazine—Crohn's disease	0.000151	0.00198	CcSEcCtD
Ganciclovir—Discomfort—Azathioprine—Crohn's disease	0.000151	0.00198	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000151	0.00517	CbGpPWpGaD
Ganciclovir—Malaise—Mesalazine—Crohn's disease	0.000148	0.00193	CcSEcCtD
Ganciclovir—Vertigo—Mesalazine—Crohn's disease	0.000147	0.00193	CcSEcCtD
Ganciclovir—Leukopenia—Mesalazine—Crohn's disease	0.000147	0.00192	CcSEcCtD
Ganciclovir—Nausea—Mercaptopurine—Crohn's disease	0.000146	0.00191	CcSEcCtD
Ganciclovir—Infection—Azathioprine—Crohn's disease	0.000146	0.00191	CcSEcCtD
Ganciclovir—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000144	0.00188	CcSEcCtD
Ganciclovir—Thrombocytopenia—Azathioprine—Crohn's disease	0.000144	0.00188	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000144	0.00492	CbGpPWpGaD
Ganciclovir—Cough—Mesalazine—Crohn's disease	0.000143	0.00187	CcSEcCtD
Ganciclovir—Skin disorder—Azathioprine—Crohn's disease	0.000143	0.00187	CcSEcCtD
Ganciclovir—Affect lability—Prednisone—Crohn's disease	0.000142	0.00185	CcSEcCtD
Ganciclovir—Hypertension—Mesalazine—Crohn's disease	0.000141	0.00185	CcSEcCtD
Ganciclovir—Psychotic disorder—Prednisone—Crohn's disease	0.000141	0.00184	CcSEcCtD
Ganciclovir—Chest pain—Mesalazine—Crohn's disease	0.000139	0.00182	CcSEcCtD
Ganciclovir—Arthralgia—Mesalazine—Crohn's disease	0.000139	0.00182	CcSEcCtD
Ganciclovir—Myalgia—Mesalazine—Crohn's disease	0.000139	0.00182	CcSEcCtD
Ganciclovir—Anxiety—Mesalazine—Crohn's disease	0.000139	0.00182	CcSEcCtD
Ganciclovir—Face oedema—Prednisone—Crohn's disease	0.000139	0.00182	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000138	0.00181	CcSEcCtD
Ganciclovir—Discomfort—Mesalazine—Crohn's disease	0.000138	0.0018	CcSEcCtD
Ganciclovir—Irritability—Prednisone—Crohn's disease	0.000137	0.0018	CcSEcCtD
Ganciclovir—Hypotension—Azathioprine—Crohn's disease	0.000137	0.00179	CcSEcCtD
Ganciclovir—Cardiac arrest—Prednisone—Crohn's disease	0.000137	0.00179	CcSEcCtD
Ganciclovir—Dry mouth—Mesalazine—Crohn's disease	0.000136	0.00178	CcSEcCtD
Ganciclovir—Mood swings—Prednisone—Crohn's disease	0.000136	0.00178	CcSEcCtD
Ganciclovir—Confusional state—Mesalazine—Crohn's disease	0.000135	0.00176	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000134	0.00175	CcSEcCtD
Ganciclovir—Oedema—Mesalazine—Crohn's disease	0.000134	0.00175	CcSEcCtD
Ganciclovir—Anaphylactic shock—Mesalazine—Crohn's disease	0.000134	0.00175	CcSEcCtD
Ganciclovir—Infection—Mesalazine—Crohn's disease	0.000133	0.00174	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000132	0.00453	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000132	0.00453	CbGpPWpGaD
Ganciclovir—Dry skin—Prednisone—Crohn's disease	0.000132	0.00173	CcSEcCtD
Ganciclovir—Hypokalaemia—Prednisone—Crohn's disease	0.000131	0.00171	CcSEcCtD
Ganciclovir—Thrombocytopenia—Mesalazine—Crohn's disease	0.000131	0.00171	CcSEcCtD
Ganciclovir—Tachycardia—Mesalazine—Crohn's disease	0.00013	0.00171	CcSEcCtD
Ganciclovir—Skin disorder—Mesalazine—Crohn's disease	0.00013	0.0017	CcSEcCtD
Ganciclovir—Hyperhidrosis—Mesalazine—Crohn's disease	0.000129	0.00169	CcSEcCtD
Ganciclovir—Anorexia—Mesalazine—Crohn's disease	0.000127	0.00167	CcSEcCtD
Ganciclovir—Muscular weakness—Prednisone—Crohn's disease	0.000127	0.00166	CcSEcCtD
Ganciclovir—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000127	0.00166	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000127	0.00435	CbGpPWpGaD
Ganciclovir—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000127	0.00166	CcSEcCtD
Ganciclovir—Abdominal distension—Prednisone—Crohn's disease	0.000125	0.00164	CcSEcCtD
Ganciclovir—Hypotension—Mesalazine—Crohn's disease	0.000125	0.00163	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000123	0.00422	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000123	0.00422	CbGpPWpGaD
Ganciclovir—Pancreatitis—Prednisone—Crohn's disease	0.000122	0.0016	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000122	0.00159	CcSEcCtD
Ganciclovir—Feeling abnormal—Azathioprine—Crohn's disease	0.000121	0.00158	CcSEcCtD
Ganciclovir—Insomnia—Mesalazine—Crohn's disease	0.000121	0.00158	CcSEcCtD
Ganciclovir—Paraesthesia—Mesalazine—Crohn's disease	0.00012	0.00157	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00012	0.00157	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00012	0.0041	CbGpPWpGaD
Ganciclovir—Dyspnoea—Mesalazine—Crohn's disease	0.000119	0.00156	CcSEcCtD
Ganciclovir—Somnolence—Mesalazine—Crohn's disease	0.000119	0.00156	CcSEcCtD
Ganciclovir—Dyspepsia—Mesalazine—Crohn's disease	0.000118	0.00154	CcSEcCtD
Ganciclovir—Neutropenia—Prednisone—Crohn's disease	0.000116	0.00152	CcSEcCtD
Ganciclovir—Decreased appetite—Mesalazine—Crohn's disease	0.000116	0.00152	CcSEcCtD
Ganciclovir—Abdominal pain—Azathioprine—Crohn's disease	0.000116	0.00152	CcSEcCtD
Ganciclovir—Body temperature increased—Azathioprine—Crohn's disease	0.000116	0.00152	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000115	0.00151	CcSEcCtD
Ganciclovir—Fatigue—Mesalazine—Crohn's disease	0.000115	0.00151	CcSEcCtD
Ganciclovir—Erectile dysfunction—Prednisone—Crohn's disease	0.000115	0.0015	CcSEcCtD
Ganciclovir—Constipation—Mesalazine—Crohn's disease	0.000114	0.0015	CcSEcCtD
Ganciclovir—Pain—Mesalazine—Crohn's disease	0.000114	0.0015	CcSEcCtD
Ganciclovir—Weight decreased—Prednisone—Crohn's disease	0.000113	0.00147	CcSEcCtD
Ganciclovir—Hyperglycaemia—Prednisone—Crohn's disease	0.000112	0.00147	CcSEcCtD
Ganciclovir—Feeling abnormal—Mesalazine—Crohn's disease	0.00011	0.00144	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000109	0.00143	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Prednisone—Crohn's disease	0.000109	0.00142	CcSEcCtD
Ganciclovir—Hypersensitivity—Azathioprine—Crohn's disease	0.000108	0.00141	CcSEcCtD
Ganciclovir—Urticaria—Mesalazine—Crohn's disease	0.000106	0.00139	CcSEcCtD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000106	0.00363	CbGpPWpGaD
Ganciclovir—Body temperature increased—Mesalazine—Crohn's disease	0.000106	0.00138	CcSEcCtD
Ganciclovir—Abdominal pain—Mesalazine—Crohn's disease	0.000106	0.00138	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000104	0.00355	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000104	0.00355	CbGpPWpGaD
Ganciclovir—Diarrhoea—Azathioprine—Crohn's disease	0.0001	0.00131	CcSEcCtD
Ganciclovir—Haemoglobin—Prednisone—Crohn's disease	0.0001	0.00131	CcSEcCtD
Ganciclovir—Haemorrhage—Prednisone—Crohn's disease	9.96e-05	0.0013	CcSEcCtD
Ganciclovir—Hallucination—Prednisone—Crohn's disease	9.91e-05	0.0013	CcSEcCtD
Ganciclovir—Hypersensitivity—Mesalazine—Crohn's disease	9.85e-05	0.00129	CcSEcCtD
Ganciclovir—Connective tissue disorder—Prednisone—Crohn's disease	9.78e-05	0.00128	CcSEcCtD
Ganciclovir—Dizziness—Azathioprine—Crohn's disease	9.7e-05	0.00127	CcSEcCtD
Ganciclovir—Asthenia—Mesalazine—Crohn's disease	9.59e-05	0.00126	CcSEcCtD
Ganciclovir—Pruritus—Mesalazine—Crohn's disease	9.46e-05	0.00124	CcSEcCtD
Ganciclovir—Vomiting—Azathioprine—Crohn's disease	9.33e-05	0.00122	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.31e-05	0.00319	CbGpPWpGaD
Ganciclovir—Rash—Azathioprine—Crohn's disease	9.25e-05	0.00121	CcSEcCtD
Ganciclovir—Dermatitis—Azathioprine—Crohn's disease	9.24e-05	0.00121	CcSEcCtD
Ganciclovir—Headache—Azathioprine—Crohn's disease	9.19e-05	0.0012	CcSEcCtD
Ganciclovir—Diarrhoea—Mesalazine—Crohn's disease	9.15e-05	0.0012	CcSEcCtD
Ganciclovir—Angiopathy—Prednisone—Crohn's disease	9.03e-05	0.00118	CcSEcCtD
Ganciclovir—Arrhythmia—Prednisone—Crohn's disease	8.89e-05	0.00116	CcSEcCtD
Ganciclovir—Dizziness—Mesalazine—Crohn's disease	8.84e-05	0.00116	CcSEcCtD
Ganciclovir—Alopecia—Prednisone—Crohn's disease	8.8e-05	0.00115	CcSEcCtD
Ganciclovir—Mental disorder—Prednisone—Crohn's disease	8.72e-05	0.00114	CcSEcCtD
Ganciclovir—Nausea—Azathioprine—Crohn's disease	8.72e-05	0.00114	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.68e-05	0.00297	CbGpPWpGaD
Ganciclovir—Malnutrition—Prednisone—Crohn's disease	8.67e-05	0.00113	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.64e-05	0.00296	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.64e-05	0.00296	CbGpPWpGaD
Ganciclovir—Vomiting—Mesalazine—Crohn's disease	8.5e-05	0.00111	CcSEcCtD
Ganciclovir—Rash—Mesalazine—Crohn's disease	8.43e-05	0.0011	CcSEcCtD
Ganciclovir—Dermatitis—Mesalazine—Crohn's disease	8.42e-05	0.0011	CcSEcCtD
Ganciclovir—Headache—Mesalazine—Crohn's disease	8.37e-05	0.0011	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.23e-05	0.00282	CbGpPWpGaD
Ganciclovir—Vision blurred—Prednisone—Crohn's disease	8.17e-05	0.00107	CcSEcCtD
Ganciclovir—Ill-defined disorder—Prednisone—Crohn's disease	8.04e-05	0.00105	CcSEcCtD
Ganciclovir—Anaemia—Prednisone—Crohn's disease	8.01e-05	0.00105	CcSEcCtD
Ganciclovir—Agitation—Prednisone—Crohn's disease	7.96e-05	0.00104	CcSEcCtD
Ganciclovir—Nausea—Mesalazine—Crohn's disease	7.94e-05	0.00104	CcSEcCtD
Ganciclovir—Malaise—Prednisone—Crohn's disease	7.81e-05	0.00102	CcSEcCtD
Ganciclovir—Vertigo—Prednisone—Crohn's disease	7.79e-05	0.00102	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.67e-05	0.00263	CbGpPWpGaD
Ganciclovir—Convulsion—Prednisone—Crohn's disease	7.51e-05	0.000983	CcSEcCtD
Ganciclovir—Hypertension—Prednisone—Crohn's disease	7.48e-05	0.000979	CcSEcCtD
Ganciclovir—Myalgia—Prednisone—Crohn's disease	7.38e-05	0.000965	CcSEcCtD
Ganciclovir—Arthralgia—Prednisone—Crohn's disease	7.38e-05	0.000965	CcSEcCtD
Ganciclovir—Anxiety—Prednisone—Crohn's disease	7.35e-05	0.000962	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	7.33e-05	0.000959	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.29e-05	0.0025	CbGpPWpGaD
Ganciclovir—Discomfort—Prednisone—Crohn's disease	7.29e-05	0.000954	CcSEcCtD
Ganciclovir—Anaphylactic shock—Prednisone—Crohn's disease	7.07e-05	0.000926	CcSEcCtD
Ganciclovir—Oedema—Prednisone—Crohn's disease	7.07e-05	0.000926	CcSEcCtD
Ganciclovir—Infection—Prednisone—Crohn's disease	7.03e-05	0.00092	CcSEcCtD
Ganciclovir—Tachycardia—Prednisone—Crohn's disease	6.9e-05	0.000903	CcSEcCtD
Ganciclovir—Skin disorder—Prednisone—Crohn's disease	6.87e-05	0.000899	CcSEcCtD
Ganciclovir—Hyperhidrosis—Prednisone—Crohn's disease	6.84e-05	0.000895	CcSEcCtD
Ganciclovir—Anorexia—Prednisone—Crohn's disease	6.74e-05	0.000882	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.71e-05	0.0023	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.71e-05	0.0023	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.45e-05	0.00221	CbGpPWpGaD
Ganciclovir—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.44e-05	0.000843	CcSEcCtD
Ganciclovir—Insomnia—Prednisone—Crohn's disease	6.4e-05	0.000837	CcSEcCtD
Ganciclovir—Paraesthesia—Prednisone—Crohn's disease	6.35e-05	0.000831	CcSEcCtD
Ganciclovir—Dyspepsia—Prednisone—Crohn's disease	6.23e-05	0.000815	CcSEcCtD
Ganciclovir—Decreased appetite—Prednisone—Crohn's disease	6.15e-05	0.000805	CcSEcCtD
Ganciclovir—Fatigue—Prednisone—Crohn's disease	6.1e-05	0.000798	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.09e-05	0.00209	CbGpPWpGaD
Ganciclovir—Constipation—Prednisone—Crohn's disease	6.05e-05	0.000791	CcSEcCtD
Ganciclovir—Feeling abnormal—Prednisone—Crohn's disease	5.83e-05	0.000763	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Prednisone—Crohn's disease	5.78e-05	0.000757	CcSEcCtD
Ganciclovir—Urticaria—Prednisone—Crohn's disease	5.62e-05	0.000735	CcSEcCtD
Ganciclovir—Body temperature increased—Prednisone—Crohn's disease	5.59e-05	0.000732	CcSEcCtD
Ganciclovir—Abdominal pain—Prednisone—Crohn's disease	5.59e-05	0.000732	CcSEcCtD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.44e-05	0.00186	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.38e-05	0.00184	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Prednisone—Crohn's disease	5.21e-05	0.000682	CcSEcCtD
Ganciclovir—Asthenia—Prednisone—Crohn's disease	5.07e-05	0.000664	CcSEcCtD
Ganciclovir—Pruritus—Prednisone—Crohn's disease	5e-05	0.000655	CcSEcCtD
Ganciclovir—Diarrhoea—Prednisone—Crohn's disease	4.84e-05	0.000633	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.73e-05	0.00162	CbGpPWpGaD
Ganciclovir—Dizziness—Prednisone—Crohn's disease	4.68e-05	0.000612	CcSEcCtD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.57e-05	0.00156	CbGpPWpGaD
Ganciclovir—Vomiting—Prednisone—Crohn's disease	4.5e-05	0.000588	CcSEcCtD
Ganciclovir—Rash—Prednisone—Crohn's disease	4.46e-05	0.000584	CcSEcCtD
Ganciclovir—Dermatitis—Prednisone—Crohn's disease	4.46e-05	0.000583	CcSEcCtD
Ganciclovir—Headache—Prednisone—Crohn's disease	4.43e-05	0.00058	CcSEcCtD
Ganciclovir—Nausea—Prednisone—Crohn's disease	4.2e-05	0.00055	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.18e-05	0.00143	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.81e-05	0.00131	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	3.7e-05	0.00127	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTMR3—Crohn's disease	3.14e-05	0.00108	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.96e-05	0.00101	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	2.76e-05	0.000946	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—FADS1—Crohn's disease	2.45e-05	0.000839	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	2.32e-05	0.000795	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GPX4—Crohn's disease	2.29e-05	0.000786	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GCKR—Crohn's disease	2.22e-05	0.000759	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.94e-05	0.000664	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.51e-05	0.000516	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ALB—Crohn's disease	7.05e-06	0.000242	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—Crohn's disease	6.17e-06	0.000211	CbGpPWpGaD
